Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema

202252 citationsJournal Articlehybrid Open Access

Authors

Michael Singer · Medical Center Ophthalmology Associates

Veeral Sheth · Illinois Retina Associates

Sam E. Mansour · George Washington University

Brandon Coughlin · Alimera Sciences (United States)

Víctor H. González · Valley Retina Institute

Abstract

In patients with DME, the 0.19-mg FAc implant provided improved visual outcomes and reduced treatment burden compared with previous treatments while maintaining a favorable safety profile.

Topics & Keywords

Retinal Diseases and Treatments Glaucoma and retinal disorders Retinal Imaging and Analysis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Ophthalmology

Volume 129, Issue 6, pp. 605-613

DOI: 10.1016/j.ophtha.2022.01.015

Field-Weighted Citation Impact: 9.59